The role of postoperative radiation and chemoradiation in Merkel cell carcinoma: A systematic review of the literature

Frontiers in Oncology

Volumn 3 NOV, Issue , 2013, Pages

  Hasan, Shaakir ^a   Liu, Liyu ^a   Triplet, Jacob ^a   Li, Zhen ^b   Mansur, David ^c  

^a affiliation with Nova Southeastern College of Osteopathic Medicine   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

Adjuvant radiotherapy; Chemoradiation; Merkel cell carcinoma; Postoperative radiation Merkel; Review

Indexed keywords

CANCER CONTROL; CANCER RECURRENCE; CANCER STAGING; CHEMORADIOTHERAPY; CHEMOSURGERY; FOLLOW UP; HUMAN; MERKEL CELL TUMOR; META ANALYSIS (TOPIC); OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRACTICE GUIDELINE; REVIEW; SYSTEMATIC REVIEW; TUMOR VOLUME;

EID: 84891050587     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2013.00276     Document Type: Review

References (51)

1. Agelli M, Clegg LX. Epidemiology of primary Merkel cell carcinoma in the United States. J Am Acad Dermatol (2003) 49:832-41. doi:10.1016/S0190-9622(03)02108-X
2. Akhtar S, Oza KK, Wright J. Merkel cell carcinoma: report of 10 cases and review of the literature. J Am Acad Dermatol (2000) 43:755-67. doi:10.1067/mjd.2000.106505
3. Allen PJ, Bowne WB, Jaques DP, Brennan MF, Busam K, Coit DG. Merkel cell carcinoma: prognosis and treatment of patients from a single institution. J Clin Oncol (2005) 23:2300-9. doi:10.1200/JCO.2005.02.329
4. Baumann KI, Halata Z, Moll I, editors. The Merkel Cell: Structure-Development-Function-Cancerogenesis. Berlin: Springer (2003). p 1-248.
5. Bichakjian CK, Lowe L, Lao CD, Sandler HM, Bradford CR, Johnson TM, et al. Merkel cell carcinoma: critical review with guidelines for multidisciplinary management. Cancer (2007) 110:1-12. doi:10.1002/cncr.22765
6. Boyer JD, Zitelli JA, Brodland DG, D'Angelo G. Local control of primary Merkel cell carcinoma: review of 45 cases treated with Mohs micrographic surgery with and without adjuvant radiation. J Am Acad Dermatol (2002) 47:885-92. doi:10.1067/mjd.2002.125083
7. Boyle F, Pendlebury S, Bell D. Further insights into the natural history and management of primary cutaneous neuroendocrine (Merkel cell) carcinoma. Int J Radiat Oncol Biol Phys (1995) 31:315-23. doi:10.1016/0360-3016(93)E0110-R
8. Clark JR, Veness MJ, Gilbert R, O'Brien CJ, Gullane PJ. Merkel cell carcinoma of the head and neck: is adjuvant radiotherapy necessary? Head Neck (2007) 29:249-57. doi:10.1002/hed.20510
9. Desch L, Kunstfeld R. Merkel cell carcinoma: chemotherapy and emerging new therapeutic options. J Skin Cancer (2013) 2013:327150. doi:10.1155/2013/327150
10. Eich HT, Eich D, Staar S, Mauch C, Stutzer H, Groth W, et al. Role of postoperative radiotherapy in the management of Merkel cell carcinoma. Am J Clin Oncol (2002) 25:50-6.
11. Eng TY, Boersma MG, Fuller CD, Cavanaugh SX, Valenzuela F, Herman TS. Treatment of Merkel cell carcinoma. Am J Clin Oncol (2004) 27:510-5. doi:10.1590/S1807-59322011001000023
12. Engels EA, Frisch M, Goedert JJ, Biggar RJ, Miller RW. Merkel cell carcinoma and HIV infection. Lancet (2002) 359:497-8. doi:10.1016/S0140-6736(02)07668-7
13. Feng H, Shuda M, Chang Y, Moore PS. Clonal integration of a polyomarvirus in human Merkel cell carcinoma. Science (2008) 319:1096-100. doi:10.1126/science.1152586
14. Fenig E, Brenner B, Katz A, Rakovsky E, Hana MB, Sulkes A. The role of radiation therapy and chemotherapy in the treatment of Merkel cell carcinoma. Cancer (1997) 80:881-5.
15. Fields RC, Busam KJ, Chou JF, Panageas KS, Pulitzer MP, Allen PJ, et al. Recurrence after complete resection and selective use of adjuvant therapy for stage I through III Merkel cell carcinoma. Cancer (2012) 118:3311-20. doi:10.1002/cncr.26626
16. Shalhub S, Clarke L, Morgan MB. Chemotherapy for metastatic Merkel cell carcinoma. Cancer (1985) 56:1034-8.
17. Ghadjar P, Kaanders JH, Poortmans P, Zaucha R, Krengli M, Lagrange JL, et al. The essential role of radiotherapy in the treatment of Merkel cell carcinoma: a study from the rare cancer network. Int J Radiat Oncol Biol Phys (2011) 81:e583-91. doi:10.1016/j.ijrobp.2011.05.028
18. Gillenwater AM, Hessel AC, Morrison WH, Burgess M, Silva EG, Roberts D, et al. Merkel cell carcinoma of the head and neck: effect of surgical excision and radiation on recurrence and survival. Arch Otolaryngol Head Neck Surg (2001) 127:149-54. doi:10.1001/archotol.127.2.149
19. Goessling W, McKee PH, Mayer RJ. Merkel cell carcinoma. J Clin Oncol (2002) 20:588-98. doi:10.1200/JCO.20.2.588
20. Halata Z, Baumann KI. Friedrich Sigmund Merkel and his "Merkel cell," morphology, development, and physiology: review and new results. Anat Rec A Discov Mol Cell Evol Biol (2003) 271:225-39. doi:10.1002/ar.a.10029
21. Heath M, Jaimes N, Lemos B, Mostaghimi A, Wang LC, Peñas PF, et al. Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the Aeiou features. J Am Acad Dermatol (2008) 58:375-81. doi:10.1016/j.jaad.2007.11.020
22. Howle JR, Hughes TM, Gebski V, Veness MJ. Merkel cell carcinoma: an Australian perspective and the importance of addressing the regional lymph nodes in clinically node-negative patients. J Am Acad Dermatol (2012) 67:33-40. doi:10.1016/j.jaad.2011.07.029
23. Hui AC, Stillie AL, Seel M, Ainslie J. Merkel cell carcinoma: 27-year experience at the Peter Maccallum cancer centre. Int J Radiat Oncol Biol Phys (2011) 80:1430-5. doi:10.1016/j.ijrobp.2010.04.061
24. Jabbour J, Cumming R, Scolyer RA, Hruby G, Thompson JF, Lee S. Merkel cell carcinoma: assessing the effect of wide local excision, lymph node dissection, and radiotherapy on recurrence and survival in early-stage disease-results from a review of 82 consecutive cases diagnosed between 1992 and 2004. Ann Surg Oncol (2007) 14:1943-52. doi:10.1245/s10434-006-9327-y
25. Kim JA, Choi AH. Effect of radiation therapy on survival in patients with resected Merkel cell carcinoma: a propensity score surveillance, epidemiology, and end results database analysis. JAMA Dermatol (2013) 149:831-8. doi:10.1001/jamadermatol.2013.409
26. Lawenda BD, Thiringer JK, Foss RD, Johnston PAS. Merkel cell carcinoma arising in the head and neck. Am J Clin Oncol (2001) 24:35-42.
27. Lee J, Poon I, Balogh J, Tsao M, Barnes E. A review of radiotherapy for Merkel cell carcinoma of the head and neck. J Skin Cancer (2012) 2012:563829. doi:10.1155/2012/563829
28. Lok B, Khan S, Mutter R, Liu J, Fields R, Pulitzer M, et al. Selective radiotherapy for the treatment of head and neck Merkel cell carcinoma. Cancer (2012) 118:3937-44. doi:10.1002/cncr.26738
29. Lunder EJ, Stern RS. Merkel cell carcinomas in patients treated with methoxsalen and ultraviolet a radiation. N Engl J Med (1998) 339:1247-8.
30. Medina-Franco H, Urist MM, Fiveash J, Heslin MJ, Bland KI, Beenken SW. Multimodality treatment of Merkel cell carcinoma: case series and literature review of 1024 cases. Ann Surg Oncol (2001) 8:204-8.
31. Meeuwissen JA, Bourne RG, Kearsley JH. The importance of postoperative radiation therapy in the treatment of Merkel cell carcinoma. Int J Radiat Oncol Biol Phys (1995) 31:325-31.
32. Miller RW, Rabkin CS. Merkel cell carcinoma and melanoma: etiological similarities and differences. Cancer Epidemiol Biomarkers Prev (1999) 8:153-8.
33. Mojica P, Smith D, Ellenhorn JD. Adjuvant radiation therapy is associated with improved survival in Merkel cell carcinoma of the skin. J Clin Oncol (2007) 25:1043-7. doi:10.1200/JCO.2006.07.9319
34. Ott MJ, Tanabe KK, Gadd MA, Stark P, Smith BL, Finkelstein DM, et al. Multimodality management of Merkel cell carcinoma. Arch Surg (1999) 134:388-93.
35. Pectasides D, Papaxoinis G, Pectasides E, Galani H, Razi E, Katodrytis N, et al. Merkel cell carcinoma of the skin: a retrospective study of 24 cases by the Hellenic Cooperative Oncology Group. Oncology (2007) 72:211-8. doi:10.1159/000112944
36. Penn I, First MR. Merkel's cell carcinoma in organ recipients: report of 41 cases. Transplantation (1999) 68:1717-21.
37. Poulsen MG, Rischin D, Porter I, Walpole E, Harvey J, Hamilton C, et al. Does chemotherapy improve survival in high-risk stage I and II Merkel cell carcinoma of the skin? Int J Radiat Oncol Biol Phys (2006) 64:114-9. doi:10.1016/j.ijrobp.2005.04.042
38. Poulsen M, Rischin D. Merkel cell carcinoma-current therapeutic options. Expert Opin Pharmacother (2003) 4:2187-92. doi:10.1517/14656566.4.12.2187
39. Poulsen M, Rischin D, Walpole E, Harvey J, Macintosh J, Ainslie J, et al. Analysis of toxicity of Merkel Cell carcinoma of the skin treated with synchronous carboplatin/etoposide and radiation: a Trans-Tasman Radiation Oncology Group Study. Int J Radiat Oncol Biol Phys (2001) 51:156-63. doi:10.1016/S0360-3016(01)01577-2
40. Poulsen M, Rischin D, Walpole E, Harvey J, Mackintosh J, Ainslie J, et al. High-risk Merkel cell carcinoma of the skin treated with synchronous carboplatin/etoposide and radiation: a Trans-Tasman Radiation Oncology Group Study-Trog 96:07. J Clin Oncol (2003) 21:4371-6. doi:10.1200/JCO.2003.03.154
41. Poulsen M, Round C, Keller J, Tripcony L, Veness M. Factors influencing relapse-free survival in Merkel cell carcinoma of the lower limb-a review of 60 cases. Int J Radiat Oncol Biol Phys (2010) 76:393-7. doi:10.1016/j.ijrobp.2009.02.014
42. Poulsen M, Walpole E, Harvey J, Dickie G, O'Brien P, Keller J, et al. Weekly carboplatin reduces toxicity during synchronous chemoradiotherapy for Merkel cell carcinoma of skin. Int J Radiat Oncol Biol Phys (2008) 72:1070-4. doi:10.1016/j.ijrobp.2008.02.076
43. Senchenkov A, Barnes SA, Moran SL. Predictors of survival and recurrence in the surgical treatment of Merkel cell carcinoma of the extremities. J Surg Oncol (2007) 95:229-34. doi:10.1002/jso.20647
44. Senchenkov A, Moran SL. Merkel cell carcinoma: diagnosis, management, and outcomes. Plast Reconstr Surg (2013) 131:771-8. doi:10.1097/PRS.0b013e3182865cf3
45. Soult MC, Feliberti EC, Silverberg ML, Perry RR. Merkel cell carcinoma: high recurrence rate despite aggressive treatment. J Surg Res (2012) 177:75-80. doi:10.1016/j.jss.2012.03.067
46. Tai PTH, Yu E, Winquist E, Hammond A, Stitt L, Tonita J, et al. Chemotherapy in neuroendocrine/Merkel cell carcinoma of the skin: case series and review of 204 cases. J Clin Oncol (2000) 18:2493-9.
47. Tarantola TI, Vallow LA, Halyard MY, Weenig RH, Warschaw KE, Grotz TE, et al. Prognostic factors in Merkel Cell carcinoma: analysis of 240 cases. J Am Acad Dermatol (2013) 68:425-32. doi:10.1016/j.jaad.2012.09.036
48. Van Gele M, Kaghad M, Leonard JH, Van Roy N, Naeyaert JM, Geerts ML, et al. Mutation analysis of P73 and Tp53 in Merkel cell carcinoma. Br J Cancer (2000) 82:823-6. doi:10.1054/bjoc.1999.1006
49. Warner RE, Quinn MJ, Hruby G, Scolyer RA, Uren RF, Thompson JF. Management of Merkel cell carcinoma: the roles of lymphoscintigraphy, sentinel lymph node biopsy and adjuvant radiotherapy. Ann Surg Oncol (2008) 15:2509-18. doi:10.1245/s10434-008-9983-1
50. Wobser M, Kurzinger N, Ugurel S, Brocker EB, Becker JC. Therapy of metastasized Merkel cell carcinoma with liposomal doxorubicin in combination with radiotherapy. J Dtsch Dermatol Ges (2009) 7:521-5. doi:10.1111/j.1610-0387.2008.06990.x
51. Wong KC, Zuletta F, Clarke SJ, Kenndy PJ. Clinical management and treatment outcomes of Merkel cell carcinoma. Aust N Z J Surg (1998) 68:354-8.